-
Since its introduction in 2009, use of the non-latex FC2 Female Condom (Women's Health Co., Chicago) has grown.
-
While it is not in the top tier of contraceptive effectiveness, the diaphragm remains an option as a female-controlled method of birth control. What do you know about this form of family planning?
-
What is your practice when it comes to screening women for chlamydia? The Centers for Disease Control and Prevention (CDC) recommends annual chlamydia screening for all sexually active young women age 25 and younger.
-
Your next patient is a young woman who was in two months ago for a chlamydia infection. You provided her with a prescription and asked that she have her partner come in for evaluation, testing, and treatment.
-
While the human papillomavirus (HPV) vaccine has been approved for use in men, how many are open to receiving it? New research indicates men might be more willing to receive vaccination when they learn the vaccine can prevent cancer.
-
Findings from a new national report reflect an increase in the use of early medication abortion.
-
Many women might choose the contraceptive injection depot medroxyprogesterone acetate (DMPA, Depo-Provera) for its ease of use, but they might discontinue the method due to irregular bleeding.
-
Add new information in your counseling dialogue regarding the human papillomavirus (HPV) vaccine Gardasil.
-
Can same pre-exposure prophylaxis results be recreated in real life?
-
Among the seemingly countless provisions in the March 2010 health reform law is one that greatly simplifies the process by which a state may extend Medicaid eligibility for family planning services and supplies to individuals ineligible for comprehensive health coverage under the program.